Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Identification of prostate cancer-associated microRNAs in circulation using a mouse model of disease|
|Citation:||Circulating MicroRNAs. Methods and Protocols, 2013 / Ochiya, T. (ed./s), pp.235-246|
|Luke A. Selth, Scott L. Townley, Joanna L. Gillis, Wayne D. Tilley, and Lisa M. Butler|
|Abstract:||MicroRNAs (miRNAs) derived from the cell-free fractions of blood are emerging as useful noninvasive markers of cancer. However, many tumors display significant molecular heterogeneity, which is likely to be reflected in the circulating miRNA fingerprints associated with that pathology. One strategy to minimize such heterogeneity is to employ genetically engineered mouse models of human cancer. Here, we describe a method to profile miRNAs in the serum of a mouse model of prostate cancer, TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP), and discuss practical considerations for translating these potential biomarkers into a clinical setting.|
|Keywords:||Circulating; microRNA; Mouse model; Plasma; Prostate cancer; Serum; TRAMP|
|Rights:||© Springer Science+Business Media New York 2013|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.